| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |